Cargando…

Genetic modifiers of hypertension in sGC-deficient mice

Detalles Bibliográficos
Autor principal:	Buys, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765585/ http://dx.doi.org/10.1186/2050-6511-14-S1-O8

Ejemplares similares

Phenotypes of sGC mutant mice in basic conditions, disease and shock
por: Brouckaert, Peter, et al.
Publicado: (2009)

Structural insights into sGC
por: Akker, Focco van den, et al.
Publicado: (2009)

Targeting native and apo-sGC
por: Struthers, Mary, et al.
Publicado: (2013)

Molecular aspects of sGC regulation
por: Marletta, Michael A, et al.
Publicado: (2011)

Conformational changes involved in sGC activation
por: Marletta, Michael A, et al.
Publicado: (2013)

New clinical results with sGC stimulators
por: Behr, Jürgen
Publicado: (2011)

A molecular view of the regulation of sGC activity
por: Marletta, Michael A, et al.
Publicado: (2009)

Structural insights into sGC activation by different activators
por: van den Akker, Focco, et al.
Publicado: (2011)

Mechanisms driving heme insertion into apo-sGC during its maturation in cells
por: Stuehr, Dennis, et al.
Publicado: (2013)

sGCα(1)-deficient mice: a novel murine model of spontaneous primary open angle glaucoma
por: Buys, Emmanuel S, et al.
Publicado: (2011)

Synthesis and evaluation of bifunctional sGC regulators
por: Chrominski, Mikolaj, et al.
Publicado: (2013)

Soluble guanylate cyclase crystal clear: 1(st) crystal structure of the wild-type human heterodimeric sGC catalytic domains and implications for activity
por: Seeger, Franziska, et al.
Publicado: (2013)

Lack of correlation between sGC subunit expression and sGC activity in cerebral development is due to non-heterodimerizing subunits in vivo
por: Haase, Nadine, et al.
Publicado: (2009)

Genetic silencing of sGC β1 in cancer: role of epigenetic regulation
por: Sotolongo, Alex, et al.
Publicado: (2013)

G-protein signaling modulator 1 is a modifier of sGC-dependent vascular response
por: Britton, George, et al.
Publicado: (2013)

sGCα(1)β(1 )attenuates cardiac dysfunction and mortality in murine inflammatory shock models
por: Buys, Emmanuel S, et al.
Publicado: (2009)

New vitamin B(12) derivatives activates sGC
por: Gryko, Dorota, et al.
Publicado: (2011)

Gemfibrozil as a potential heme-independent sGC activator
por: Sobolevsky, Michael, et al.
Publicado: (2011)

Inhaled nitric oxide: an sGC-dependent IOP lowering agent
por: Lieb, Wolfgang S, et al.
Publicado: (2015)

sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung
por: Egemnazarov, Bakytbek, et al.
Publicado: (2009)

Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension
por: Jones, Emma S, et al.
Publicado: (2009)

Genetic mapping of a modifier locus affecting hypertension in soluble guanylate cyclase α(1) deficient mice
por: Buys, Emmanuel S, et al.
Publicado: (2011)

Relaxant effect of BAY 41-2272 and BAY 58-2667 in the gastrointestinal tract of apo-sGC mice
por: Cosyns, Sarah, et al.
Publicado: (2011)

sGC redox regulation and asthma
por: Stuehr, Dennis J, et al.
Publicado: (2015)

Platelet inhibitory effects of the NO independent sGC stimulator riociguat (Bay 63-2561)
por: Reiss, Cora, et al.
Publicado: (2013)

Hypoxic NO-donor nitrite protects sGC-dependently against morbidity and mortality associated with sterile inflammatory shock in mice
por: Cauwels, A, et al.
Publicado: (2011)

Addressing the language needs of industry: Incorporating real-life workplace communication into SGC-based vocational English modules
por: Choi, Annie Lai-kun
Publicado: (2014)

Alternative splicing of α1 and β1 sGC genes is altered in aortic disease
por: Martin, Emil, et al.
Publicado: (2013)

Comparison of different vasodilators, endothelin antagonist, PDE5 inhibitior and sGC stimulators, in an animal model of secondary pulmonary hypertension: effects on “desaturation”
por: Becker, Eva Maria, et al.
Publicado: (2011)

SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet
por: Reverte, Virginia, et al.
Publicado: (2022)

A Zebrafish Drug-Repurposing Screen Reveals sGC-Dependent and sGC-Independent Pro-Inflammatory Activities of Nitric Oxide
por: Wittmann, Christine, et al.
Publicado: (2015)

Synergistic mutations in soluble guanylyl cyclase (sGC) reveal a key role for interfacial regions in the sGC activation mechanism
por: Childers, Kenneth C., et al.
Publicado: (2019)

Disseminated and sustained HIV-infection in CD34+ cord blood cell transplanted Rag2-/-gc-/- mice
por: Baenziger, Stefan, et al.
Publicado: (2006)

The clinical development of sGC modulators, riociguat and vericiguat
por: Misselwitz, Frank
Publicado: (2015)

Cardiovascular response to NO donors in mice deficient in NO-GC
por: Groneberg, Dieter, et al.
Publicado: (2013)

Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway
por: Beghetti, Maurice, et al.
Publicado: (2019)

Increases survival by apo-sGC activation via post-stroke blood brain barrier stabilisation and anti-inflammation
por: Langhauser, Friedericke, et al.
Publicado: (2013)

Direct evidence for close proximity of catalytic and regulatory domains of heterodimeric sGC based on fluorescence resonance energy transfer
por: Haase, Tobias, et al.
Publicado: (2009)

Effect of L-carnitine supplementation on the sGC/cGMP pathway in vascular relaxing responses from exercised rats
por: Priviero, Fernanda BM, et al.
Publicado: (2009)

Human genetics, natriuretic peptides and hypertension
por: Newton-Cheh, Christopher
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n8mcv852mbvrcs7brqqqqlrdvd